Skip to content
Skip to content
Asset 2@3x
  • Overview
  • Services
    • Patient Recruitment
    • Patient Optimization & Enrollment Boost
    • Patient Retention
    • Research Study Rockstar
  • Innovations
    • Performance-Based Pricing
  • Who We Are
  • Who We Serve
    • Sponsors
    • CROs
    • Sites & Site Networks
  • Request A Demo
  • Resource Center
  • Overview
  • Services
    • Patient Recruitment
    • Patient Optimization & Enrollment Boost
    • Patient Retention
    • Research Study Rockstar
  • Innovations
    • Performance-Based Pricing
  • Who We Are
  • Who We Serve
    • Sponsors
    • CROs
    • Sites & Site Networks
  • Request A Demo
  • Resource Center
Request a Demo
Asset 2@3x
  • Overview
  • Services
    • Patient Recruitment
    • Patient Optimization & Enrollment Boost
    • Patient Retention
    • Research Study Rockstar
  • Who We Are
  • Who We Serve
    • Sponsors
    • CROs
    • Sites & Site Networks
  • Innovations
    • Performance-Based Pricing
  • Resource Center
  • Careers
  • Overview
  • Services
    • Patient Recruitment
    • Patient Optimization & Enrollment Boost
    • Patient Retention
    • Research Study Rockstar
  • Who We Are
  • Who We Serve
    • Sponsors
    • CROs
    • Sites & Site Networks
  • Innovations
    • Performance-Based Pricing
  • Resource Center
  • Careers
Request a Demo
Asset 2@3x
  • Overview
  • Services
    • Patient Recruitment
    • Patient Optimization & Enrollment Boost
    • Patient Retention
    • Research Study Rockstar
  • Innovations
    • Performance-Based Pricing
  • Who We Are
  • Who We Serve
    • Sponsors
    • CROs
    • Sites & Site Networks
  • Request A Demo
  • Resource Center
  • Overview
  • Services
    • Patient Recruitment
    • Patient Optimization & Enrollment Boost
    • Patient Retention
    • Research Study Rockstar
  • Innovations
    • Performance-Based Pricing
  • Who We Are
  • Who We Serve
    • Sponsors
    • CROs
    • Sites & Site Networks
  • Request A Demo
  • Resource Center

News / Press

Smart Sourcing: Patient Recruitment & Retention Showcase.

Patient recruitment often breaks down where trust and understanding should begin: communication. Our new AI-driven approach bridges that gap by converting complex, Ph.D.-level protocols into plain-language conversations — tailored to each patient's education level and native language.
Read More

Beyond Awareness: Rethinking Patient Trust And Engagement In The Age Of Decentralized Trials

Over the last several years, the shift to decentralized clinical trials (DCTs) promised a future of flexibility, access, and rapid enrollment...
Read More

The Missing Link In Equal Access: Why Community-Rooted Recruitment Is The Future Of Clinical Trials

For decades, the clinical trial industry has wrestled with the question: How do we make clinical research more accessible?
Read More

From The Front Lines To First-In-Patient: How CSSi’s Local Enrollment Specialists Are Redefining Recruitment Readiness

Every sponsor wants one thing: the right patients, enrolled quickly, with minimal screen fails. But in today’s complex clinical landscape, recruitment can’t solely rely on passive referrals and generic digital outreach...
Read More

4 Proven Strategies To Optimize Patient Enrollment And Avoid Rescue Trials

In the journey to delivering innovative and potentially life-saving therapies to patients, conducting an efficient and high-quality clinical trial with your target patient population is critical...
Read More

Shattering The Status Quo: How CSSi’s AI-Powered Strategy Is Redefining Patient Recruitment Performance

The clinical research industry has long suffered from a problem no one seems able to solve: trials launch late, enroll slowly, and fail to meet recruitment goals—over and over again. For nearly two decades, the metrics have barely moved. Until now.
Read More

Articles

From Transactional To Transformative: Improving The Patient Experience In Clinical Research

As clinical trials grow in volume and diversity, drugs sponsors, CROs, sites, and vendors must adopt strategies that help improve patient engagement, experience, and retention.
Read More

The Future Of Clinical Research Enrollment: A Patient-Centric Approach

Clinical trial enrollment remains one of the biggest challenges in advancing medical research.
Read More

Harnessing Predictive Modeling To Overcome Clinical Trial Enrollment Challenges

Recruiting patients for clinical trials remains one of the most pressing challenges in drug development, with nearly 80% of trials facing delays due to enrollment hurdles.
Read More

White Papers

2025 Trends In Patient Recruitment: From Disruption To Precision

In a post-pandemic clinical research landscape defined by speed, diversity, and decentralized access, patient recruitment remains the single largest cause of trial delays.
Read More
Seamless integration

From Days to Minutes: CSSi and HumanTrue Partner to Redefine Patient Recruitment with AI

By: Mike Stratton – President CSSi
September 15, 2025

Share This Article

  • Read Original Article

LINTHICUM, Md. and SEATTLE, Sept. 15, 2025 /PRNewswire-PRWeb/
Collaboration delivers screeners in minutes, real-time translations, and AI-driven patient matching to accelerate enrollment and improve site support.

CSSi and HumanTrue today announced a partnership to bring unprecedented speed and precision to clinical trial recruitment.

By combining CSSi’s global recruitment expertise with HumanTrue’s AI platform, the collaboration will transform how patients are identified, screened, and enrolled.

At the center of the partnership are three breakthrough capabilities that address sponsors’ biggest challenges in study startup and enrollment:

  • Screeners in Minutes, Not Days – AI automatically generates patient screening questions, reducing development time from days to minutes.
  • Real-Time Translations – Instant, certified translations make study materials accessible across languages without costly delays.
  • Smarter Site Support – Study Assistant tools simplify complex protocols so sites can execute faster and with greater confidence.

Building on this foundation, the partnership will extend to AI-driven patient matching, enabling patients to quickly find and pre-qualify for relevant studies, while expanding sponsor access to more diverse populations. It allows us to connect with patients, build trust from the initial interaction and ultimately enroll at a higher percentage than the industry benchmarks.

“Sponsors want results, and patients want access,” said Mike Stratton, President. “This partnership positions CSSi at the forefront of AI-enabled recruitment. By combining HumanTrue’s AI with our performance-based recruitment model, we can deliver speed, accuracy, and scale in a way that reshapes the industry.”

“The biggest bottlenecks in recruitment are speed and complexity,” said Joan Severson, CEO of HumanTrue. “Together with CSSi, we’re turning days into minutes for screeners, making translations instant, and giving sites the tools they need to move faster. This is how enrollment timelines stay on track.”

The partnership will first focus on contracted CSSi studies, where the HumanTrue platform will accelerate pre-screening and multilingual enrollment. Longer term, the companies plan to integrate AI-optimized study listings and patient search, creating the industry’s first fully AI-native recruitment ecosystem.

Together, CSSi and HumanTrue are setting a new standard: recruitment that is faster, smarter, and more accessible for patients worldwide.

About CSSi – https://cssenroll.com
CSSi is a global leader in patient recruitment and enrollment solutions, specializing in performance-based recruitment services. With a network of Local Enrollment Specialists and deep expertise in site engagement, CSSi helps sponsors and CROs accelerate study enrollment and achieve recruitment goals across therapeutic areas.

About HumanTrue – https://humantrue.com
HumanTrue is an AI-driven clinical trial technology company that transforms complex trial protocols into actionable workflows, documents, and patient-facing experiences. HumanTrue’s platform powers informed consent, patient matching, screening automation, and multilingual trial access—making studies faster to launch and easier to understand.

Media Contact
Jeremy Westfall, CSSi, 1 601-850-1536, jeremy.westfall@elixiahealth.com, https://cssenroll.com 
Joe Gogolak, HumanTrue, joe.gogolak@humantrue.com, https://humantrue.com 

CSS Primary Logo White Logomark White Text

The CSS Difference: Designed Around Your Needs

  • 1099 Winterson Rd. Suite 136, Linthicum, MD 21090
  • 866.277.4888
  • info@cssienroll.com

© 2026 CSS. All Rights Reserved. CSS and its distinctive “CSS” logo are registered trademarks   |   Privacy Policy

Core services
  • Patient Recruitment
  • Patient Optimization & Enrollment Boost
  • Patient Retention
Who We Serve
  • Sponsors
  • CROs
  • Sites & SIte Networks
Quick links
  • Contact Us
Scroll to top